Travere Therapeutics, Inc. (TVTX): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$668.0K
Year ended 2023-12-31
-53.8%
3-year compound annual growth
-1.7%
5-year compound annual growth
+19.0%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $668.0K | +249.7% | 2024-02-20, From 2023-01-01 |
| 2022-12-31 | $191.0K | -96.3% | 2024-02-20, From 2022-01-01 |
| 2021-12-31 | $5.10M | -24.6% | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | $6.77M | n/m | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $195.0K | -73.2% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $727.0K | -18.0% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $887.0K | -37.9% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $1.43M | n/m | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $22.0K | -96.7% | 2018-07-06, From 2015-01-01 |
| 2014-12-31 | $663.0K | +466.7% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $117.0K | +372.3% | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | $24.8K | n/a | 2015-07-09, From 2012-01-01 |